The grant of fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Entero Healthcare Solutions' Board approved the grant of 7,300 fresh employee stock options under the existing ESOP Plan 2023. Additionally, 7,240 equity shares were allotted to employees who exercised their vested options. For FY26, consolidated revenue grew 29% to Rs. 65,912 million while standalone revenue declined 15% to Rs. 3,482 million due to the company operating primarily through subsidiaries. Consolidated PAT rose 36% to Rs. 1,458 million. The Board also approved re-appointment of 3 Independent Directors for a second term and set the 8th AGM for August 19, 2026.
The ESOP grant aligns employee interests with shareholders and signals management confidence. The strong consolidated growth driven by acquisitions shows successful integration, though standalone performance reflects the shift to subsidiary-based operations.